Approach To Patient
Hypoglycemia in Adults - Approach to the Patient Without Diabetes
Editors: Paul M. Copeland MD, MPhil; Heather A. Ferris MD, Phd; Allen Shaughnessy PharmD, M Med Ed, FCCP; Alan Ehrlich MD, FAAFP
General Information
Description
- hypoglycemia in persons without diabetes is a rare clinical syndrome defined as plasma glucose low enough to cause autonomic and/or neuroglycopenic signs or symptoms, including impaired brain function,,
- hypoglycemia is confirmed when Whipple triad is present,
- symptoms or signs consistent with hypoglycemia
- plasma glucose < 55 mg/dL (measured with a precise method such as a venous blood sample)
- resolution of symptoms after increasing plasma glucose level
- the causes and pathophysiology of hypoglycemia differ in patients with and without diabetes; the diagnosis and management strategies differ as well
- for more information on hypoglycemia in diabetes, see Hypoglycemia in Diabetes
Definitions
- hypoglycemia - plasma glucose low enough to cause autonomic and/or neuroglycopenic signs or symptoms, including impaired brain function
- postprandial hyperinsulinemic hypoglycemia - development of hypoglycemia within a few hours of meal ingestion
- factitious hypoglycemia - hypoglycemia that is voluntarily self-induced
- pseudohypoglycemia - an artifact of continued glucose metabolism by elements of the blood after the sample is drawn; occurs in the setting of erythrocytosis, leukocytosis, or thrombocytosis
Classifications
- historical classification fasting (postabsorptive) vs. postprandial (reactive) hypoglycemia
- no longer considered useful
- patients with some disorders (for example insulinoma) usually experience postabsorptive hypoglycemia, but may also have postprandial hypoglycemia, while other conditions (for example postgastric bypass) who typically have postprandial hypoglycemia, may have symptoms when fasting
- other disorders (for example, factitious hypoglycemia) are not easily classified as either postabsorptive or postprandial
- preferred approach is to classify patient as,
- seemingly well
- endogenous hyperinsulinism
- insulinoma
- noninsulinoma pancreatogenous hypoglycemia
- postgastric bypass hypoglycemia
- insulin autoimmunity
- antibody to insulin
- antibody to insulin receptor
- exogenous hyperinsulinism
- accidental
- factitious
- endogenous hyperinsulinism
- having a concurrent illness
- critical illness
- hepatic, renal, cardiac failure
- sepsis
- inanition
- hormone deficiency
- cortisol
- growth hormone
- glucagon
- nonbeta cell tumors
- critical illness
- taking a medication or toxin that causes hypoglycemia
- insulin or insulin secretagogue
- alcohol
- seemingly well
Incidence and Prevalence
- hypoglycemia is rare in persons who do not have drug-treated diabetes mellitus,
- postgastric bypass hypoglycemia
- reported to be < 1%, but may be underreported (Clin Endocrinol (Oxf) 2016 Jul;85(1):3)
- 0.36% prevalence of symptomatic postgastric bypass hypoglycemia in 3,082 patients who had Roux-en-Y gastric bypass in cohort study (Surg Obes Relat Dis 2008 Jul-Aug;4(4):492)
- 0.1% prevalence of self-reported hypoglycemia following Roux-en-Y gastric bypass in 145,582 patients from Bariatric Outcomes Longitudinal Database cohort (Obes Surg 2014 Jul;24(7):1120)
- 34.2% prevalence of symptoms of postbariatric hypoglycemia and 11.6% prevalence of severe symptoms of postbariatric hypoglycemia self-reported by 450 patients with Roux-en-Y gastric bypass (79%) or vertical sleeve gastrectomy (21%) in questionnaire-based cohort study (Obesity (Silver Spring) 2015 May;23(5):1079)
- STUDY SUMMARYprevalence of hospitalization for hypoglycemia following Roux-en-Y gastric bypass 0.2% in SwedenCOHORT STUDY: Diabetologia 2010 Nov;53(11):2307
- hypoglycemia in critical care patients
- STUDY SUMMARY≥ 1 episode of hypoglycemia may occur in about 5% of patients in intensive care unitCOHORT STUDY: Crit Care Med 2010 Jun;38(6):1430
- STUDY SUMMARYprevalence of hypoglycemia (≥ 1 episode) about 25% among children in intensive care unit after burn injuryCOHORT STUDY: Crit Care Med 2014 May;42(5):1221
Published by EBSCO Information Services. Copyright © 2025, EBSCO Information Services. All rights reserved. No part of this may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission.
EBSCO Information Services accepts no liability for advice or information given herein or errors/omissions in the text. It is merely intended as a general informational overview of the subject for the healthcare professional.
DynaMed Levels of Evidence
Quickly find and determine the quality of the evidence.
DynaMed provides easy-to-interpret Level of Evidence labels so users can quickly find and determine the quality of the best available evidence. Evidence may be labeled in one of three levels:
1Level 1 (likely reliable) Evidence
2Level 2 (mid-level) Evidence
3Level 3 (lacking direct) Evidence
Grades of Recommendation
Guideline producers are now frequently using classification approaches for their evidence and recommendations, and these classifications are recognized and requested by guideline users. When summarizing guideline recommendations for DynaMed users, the DynaMed Editors are using the guideline-specific classifications and providing guideline classification approach when this is done.
Download the full version of Levels of Evidence